Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors

European Journal of Pharmacology

Volumn 588, Issue 2-3, 2008, Pages 267-276

  Sousa, Teresa ^a,b   Pinho, Dora ^a   Morato, Manuela ^a,b   Marques Lopes, José ^a   Fernandes, Eduarda ^c   Afonso, Joana ^a   Oliveira, Sofia ^a   Carvalho, Félix ^c   Albino Teixeira, António ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Campus Universitário de Santiago   (Portugal)

Author keywords

Adenosine receptors; H2O2; Hypertension; Oxidative stress; Renin angiotensin system

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ANTIOXIDANT; APOCYNIN; CAPTOPRIL; CATALASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MACROGOL DERIVATIVE; OXIDIZING AGENT; OXYGEN RADICAL; POLYETHYLENE GLYCOL CATALASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ASSAY; FLUOROMETRY; HYPERTENSION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PARAMETER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE;

ACETOPHENONES; ANIMALS; BLOOD VESSELS; CATALASE; HYDROGEN PEROXIDE; HYPERTENSION; LIPID PEROXIDATION; MALE; NADPH OXIDASE; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SUPEROXIDE DISMUTASE; SUPEROXIDES; SYSTOLE; XANTHINES;

EID: 44649147663     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.044     Document Type: Article

References (68)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. Al Moutaery K., Al Deeb S., Ahmad Khan H., and Tariq M. Caffeine impairs short-term neurological outcome after concussive head injury in rats. Neurosurgery 53 (2003) 704-711 discussion 711-702
3. Albino-Teixeira A., Matias A., Polonia J., and Azevedo I. Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J. Hypertens Suppl 9 (1991) S196-S197
4. Bagchi D., Prasad R., and Das D.K. Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem. Biophys. Res. Commun. 158 (1989) 52-57
5. Bayorh M.A., Ganafa A.A., Eatman D., Walton M., and Feuerstein G.Z. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am. J. Hypertens. 18 (2005) 1496-1502
6. Beckman J.S., Minor Jr. R.L., White C.W., Repine J.E., Rosen G.M., and Freeman B.A. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 263 (1988) 6884-6892
7. Beswick R.A., Dorrance A.M., Leite R., and Webb R.C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38 (2001) 1107-1111
8. Beswick R.A., Zhang H., Marable D., Catravas J.D., Hill W.D., and Webb R.C. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37 (2001) 781-786
9. Birtwistle R.J., Michael J., Howie A.J., and Adu D. Reactive oxygen products in heterologous anti-glomerular basement membrane nephritis in rats. Br. J. Exp. Pathol. 70 (1989) 207-213
10. Bolterman R.J., Manriquez M.C., Ortiz Ruiz M.C., Juncos L.A., and Romero J.C. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46 (2005) 943-947
11. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
12. Brown M.R., Miller Jr. F.J., Li W.G., Ellingson A.N., Mozena J.D., Chatterjee P., Engelhardt J.F., Zwacka R.M., Oberley L.W., Fang X., Spector A.A., and Weintraub N.L. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ. Res. 85 (1999) 524-533
13. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ. Res. 96 (2005) 818-822
14. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24 (2003) 471-478
15. Chen Y.F., Cowley Jr. A.W., and Zou A.P. Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am. J. Physiol., Regul. Integr. Comp. Physiol. 285 (2003) R827-R833
16. Chopra M., Scott N., McMurray J., McLay J., Bridges A., Smith W.E., and Belch J.J. Captopril: a free radical scavenger. Br. J. Clin. Pharmacol. 27 (1989) 396-399
17. Csonka C., Pataki T., Kovacs P., Muller S.L., Schroeter M.L., Tosaki A., and Blasig I.E. Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic. Biol. Med. 29 (2000) 612-619
18. Dobrian A.D., Schriver S.D., and Prewitt R.L. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 38 (2001) 361-366
19. Dogra G., Ward N., Croft K.D., Mori T.A., Barrett P.H., Herrmann S.E., Irish A.B., and Watts G.F. Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential. Nephrol. Dial. Transplant. 16 (2001) 1626-1630
20. Donmez G., Derici U., Erbas D., Arinsoy T., Onk A., Sindel S., and Hasanoglu E. The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension. Jpn. J. Physiol. 52 (2002) 435-440
21. Farmand F., Ehdaie A., Roberts C.K., and Sindhu R.K. Lead-induced dysregulation of superoxide dismutases, catalase, glutathione peroxidase, and guanylate cyclase. Environ. Res. 98 (2005) 33-39
22. Fernandes E., Costa D., Toste S.A., Lima J.L., and Reis S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic. Biol. Med. 37 (2004) 1895-1905
23. Flammer A.J., Hermann F., Wiesli P., Schwegler B., Chenevard R., Hurlimann D., Sudano I., Gay S., Neidhart M., Riesen W., Ruschitzka F., Luscher T.F., Noll G., and Lehmann R. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J. Hypertens. 25 (2007) 785-791
24. Flohe L., and Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 105 (1984) 114-121
25. Flohe L., and Otting F. Superoxide dismutase assays. Methods Enzymol. 105 (1984) 93-104
26. Griendling K.K., and Harrison D.G. Dual role of reactive oxygen species in vascular growth. Circ. Res. 85 (1999) 562-563
27. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994) 1141-1148
28. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
29. Hamilton C.A., Miller W.H., Al-Benna S., Brosnan M.J., Drummond R.D., McBride M.W., and Dominiczak A.F. Strategies to reduce oxidative stress in cardiovascular disease. Clin. Sci. (Lond) 106 (2004) 219-234
30. Harris E.D. Regulation of antioxidant enzymes. FASEB J. 6 (1992) 2675-2683
31. Husain K., and Somani S.M. Interaction of exercise and adenosine receptor agonist and antagonist on rat heart antioxidant defense system. Mol. Cell. Biochem. 270 (2005) 209-214
32. Ito H., Torii M., and Suzuki T. Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin. Exp. Hypertens. 17 (1995) 803-816
33. Jackson E.K. Adenosine: a physiological brake on renin release. Annu. Rev. Pharmacol. Toxicol. 31 (1991) 1-35
34. Khattab M., Ahmad M., Al-Shabanah O.A., and Raza M. Effects of losartan on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric oxide deficient hypertensive rats. Recept. Channels 10 (2004) 147-157
35. Kobori H., and Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem. Biophys. Res. Commun. 315 (2004) 746-750
36. Lacy F., Kailasam M.T., O'Connor D.T., Schmid-Schonbein G.W., and Parmer R.J. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36 (2000) 878-884
37. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., Holland S.M., and Harrison D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40 (2002) 511-515
38. Lassegue B., and Griendling K.K. Reactive oxygen species in hypertension: an update. Am. J. Hypertens. 17 (2004) 852-860
39. Liu T.H., Beckman J.S., Freeman B.A., Hogan E.L., and Hsu C.Y. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am. J. Physiol. 256 (1989) H589-H593
40. Lounsbury K.M., Hu Q., and Ziegelstein R.C. Calcium signaling and oxidant stress in the vasculature. Free Radic. Biol. Med. 28 (2000) 1362-1369
41. Makino A., Skelton M.M., Zou A.P., and Cowley Jr. A.W. Increased renal medullary H2O2 leads to hypertension. Hypertension 42 (2003) 25-30
42. Matias A., Albino-Teixeira A., Polonia J., and Azevedo I. Long-term administration of 1,3-dipropyl-8-sulfophenylxanthine causes arterial hypertension. Eur. J. Pharmacol. 193 (1991) 101-104
43. Morato M., Sousa T., Guimaraes S., Moura D., and Albino-Teixeira A. The role of angiotensin II in hypertension due to adenosine receptors blockade. Eur. J. Pharmacol. 455 (2002) 135-141
44. Morato M., Sousa T., Guimaraes S., Moura D., and Albino-Teixeira A. Losartan and atenolol on hypertension induced by adenosine receptor blockade. Auton. Autacoid Pharmacol. 23 (2003) 133-140
45. Nie Z., Mei Y., Ford M., Rybak L., Marcuzzi A., Ren H., Stiles G.L., and Ramkumar V. Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Mol. Pharmacol. 53 (1998) 663-669
46. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
47. Paiva M.Q., Santos M.J., and Albino-Teixeira A. Endothelium-dependent vascular responses in 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) hypertensive rats. J. Pharm. Pharmacol. 49 (1997) 74-77
48. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
49. Ramkumar V., Hallam D.M., and Nie Z. Adenosine, oxidative stress and cytoprotection. Jpn. J. Pharmacol. 86 (2001) 265-274
50. Rao G.N., and Berk B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70 (1992) 593-599
51. Sainz J., Wangensteen R., Rodriguez Gomez I., Moreno J.M., Chamorro V., Osuna A., Bueno P., and Vargas F. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am. J. Hypertens. 18 (2005) 871-877
52. Scandalios J.G. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz. J. Med. Biol. Res. 38 (2005) 995-1014
53. Schnackenberg C.G., and Wilcox C.S. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33 (1999) 424-428
54. Sousa T., Morato M., and Albino-Teixeira A. Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors. Eur. J. Pharmacol. 441 (2002) 99-104
55. Sousa T., Morato M., Fernandes E., Carvalho F., and Albino-Teixeira A. Xanthine oxidase inhibition by 1,3-dipropyl-8-sulfophenylxanthine (DPSPX), an antagonist of adenosine receptors. J. Enzyme Inhib. Med. Chem. 19 (2004) 11-15
56. Stolk J., Hiltermann T.J., Dijkman J.H., and Verhoeven A.J. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 11 (1994) 95-102
57. Suvorava T., Lauer N., Kumpf S., Jacob R., Meyer W., and Kojda G. Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation 112 (2005) 2487-2495
58. Torrecillas G., Boyano-Adanez M.C., Medina J., Parra T., Griera M., Lopez-Ongil S., Arilla E., Rodriguez-Puyol M., and Rodriguez-Puyol D. The role of hydrogen peroxide in the contractile response to angiotensin II. Mol. Pharmacol. 59 (2001) 104-112
59. Touyz R.M. Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev. Cardiov. Ther. 1 (2003) 91-106
60. Virdis A., Neves M.F., Amiri F., Touyz R.M., and Schiffrin E.L. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22 (2004) 535-542
61. Wassmann S., Wassmann K., and Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44 (2004) 381-386
62. Yanes L., Romero D., Iliescu R., Cucchiarelli V.E., Fortepiani L.A., Santacruz F., Bell W., Zhang H., and Reckelhoff J.F. Systemic arterial pressure response to two weeks of Tempol therapy in SHR: involvement of NO, the RAS, and oxidative stress. Am. J. Physiol., Regul. Integr. Comp. Physiol. 288 (2005) R903-R908
63. Yang H., Roberts L.J., Shi M.J., Zhou L.C., Ballard B.R., Richardson A., and Guo Z.M. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ. Res. 95 (2004) 1075-1081
64. Yi X.Y., Li V.X., Zhang F., Yi F., Matson D.R., Jiang M.T., and Li P.L. Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle. Am. J. Physiol. 290 (2006) H1136-H1144
65. Zafari A.M., Ushio-Fukai M., Akers M., Yin Q., Shah A., Harrison D.G., Taylor W.R., and Griendling K.K. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32 (1998) 488-495
66. Zalba G., Beaumont F.J., San Jose G., Fortuno A., Fortuno M.A., Etayo J.C., and Diez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35 (2000) 1055-1061
67. Zhang Y., Handy D.E., and Loscalzo J. Adenosine-dependent induction of glutathione peroxidase 1 in human primary endothelial cells and protection against oxidative stress. Circ. Res. 96 (2005) 831-837
68. Zou A.P., Li N., and Cowley Jr. A.W. Production and actions of superoxide in the renal medulla. Hypertension 37 (2001) 547-553